NewcelX Appoints World-Renowned Diabetes Cure-Focused Pioneer, Dr. Camillo Ricordi, to Scientific Advisory Board
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="center" dir="RTL"><span dir="LTR"><em>The appointment follows </em><em>New</em><em>c</em><em>elX's</em><em> recently announced successful FDA Type B Pre-IND meeting for NCEL-101</em><em>,</em><em> providing a clear regulatory p
Overview
<link type="text/css" rel="stylesheet" href="https://www.globenewswire.com/styles/gnw_nitf.css" /><p align="center" dir="RTL"><span dir="LTR"><em>The appointment follows </em><em>New</em><em>c</em><em>elX's</em><em> recently announced successful FDA Type B Pre-IND meeting for NCEL-101</em><em>,</em><em> providing a clear regulatory pathway...
Source
Originally published at markets.businessinsider.com.
